-
1
-
-
0006108608
-
-
Viridoxins A and B, see
-
Viridoxins A and B, see. Gupta S., Krasnoff S.B., Renwick J.A.A., Roberts D.W., Steiner J.R., and Clardy J. J. Org. Chem. 58 (1993) 1062
-
(1993)
J. Org. Chem.
, vol.58
, pp. 1062
-
-
Gupta, S.1
Krasnoff, S.B.2
Renwick, J.A.A.3
Roberts, D.W.4
Steiner, J.R.5
Clardy, J.6
-
2
-
-
0031801643
-
-
Sesquicillins, see
-
Sesquicillins, see. Engel B., Erkel G., Anke T., and Sterner O. J. Antibiot. 51 (1998) 518
-
(1998)
J. Antibiot.
, vol.51
, pp. 518
-
-
Engel, B.1
Erkel, G.2
Anke, T.3
Sterner, O.4
-
3
-
-
0036335794
-
-
Jeong H.-W., Lee H.-J., Kho Y.-H., Son K.-H., Han M.Y., Lim J.-S., Lee M.-Y., Han D.C., Ha J.-H., and Kwon B.-M. Bioorg. Med. Chem. 10 (2002) 3129
-
(2002)
Bioorg. Med. Chem.
, vol.10
, pp. 3129
-
-
Jeong, H.-W.1
Lee, H.-J.2
Kho, Y.-H.3
Son, K.-H.4
Han, M.Y.5
Lim, J.-S.6
Lee, M.-Y.7
Han, D.C.8
Ha, J.-H.9
Kwon, B.-M.10
-
4
-
-
22444433146
-
-
Sesquicillin (1) has been previously reported in patent literature, hcsowever, the structural elucidation has not been described
-
Uchida R., Imasato R., Yamaguchi Y., Masuma R., K. S., Tomoda H., and Ömura S. J. Antibiot. 58 (2005) 397 Sesquicillin (1) has been previously reported in patent literature, hcsowever, the structural elucidation has not been described
-
(2005)
J. Antibiot.
, vol.58
, pp. 397
-
-
Uchida, R.1
Imasato, R.2
Yamaguchi, Y.3
Masuma, R.4
K., S.5
Tomoda, H.6
Ömura, S.7
-
5
-
-
76949103667
-
-
Sandoz Ltd., Switzerland
-
Hirschthal T.B., and Neuallschwil T.H. DE 2 316 (October 11, 1973), Sandoz Ltd., Switzerland 429
-
(1973)
DE 2
, vol.316
, pp. 429
-
-
Hirschthal, T.B.1
Neuallschwil, T.H.2
-
6
-
-
76949103380
-
-
(Nippon Kayaku K. K., Japan
-
Kuwabara A., Fujita S., Kobayashi S., and Nishigori T. JP 8 092 (April 9, 1996), (Nippon Kayaku K. K., Japan 119
-
(1996)
JP 8
, vol.92
, pp. 119
-
-
Kuwabara, A.1
Fujita, S.2
Kobayashi, S.3
Nishigori, T.4
-
7
-
-
0028845809
-
-
Subglutinols A and B, see
-
Subglutinols A and B, see. Lee J.C., Lobkovsky E., Pliam N.B., Strobel G., and Clardy J. J. Org. Chem. 60 (1995) 7076
-
(1995)
J. Org. Chem.
, vol.60
, pp. 7076
-
-
Lee, J.C.1
Lobkovsky, E.2
Pliam, N.B.3
Strobel, G.4
Clardy, J.5
-
8
-
-
0035847516
-
-
Nalanthalide, see
-
Nalanthalide, see. Goetz M.A., Zink D.L., Denzeny G., Dombrowski A., Polishook J.D., Felix J.P., Slaughter R.S., and Singh S.B. Tetrahedron Lett. 42 (2001) 1255
-
(2001)
Tetrahedron Lett.
, vol.42
, pp. 1255
-
-
Goetz, M.A.1
Zink, D.L.2
Denzeny, G.3
Dombrowski, A.4
Polishook, J.D.5
Felix, J.P.6
Slaughter, R.S.7
Singh, S.B.8
-
9
-
-
0035945743
-
-
Candelalides A-C, see
-
Candelalides A-C, see. Singh S.B., Zink D.L., Dombrowski A.W., Dezeny G., Bills G.F., Felix J.P., Slaughter R.S., and Goetz M.A. Org. Lett. 3 (2001) 247
-
(2001)
Org. Lett.
, vol.3
, pp. 247
-
-
Singh, S.B.1
Zink, D.L.2
Dombrowski, A.W.3
Dezeny, G.4
Bills, G.F.5
Felix, J.P.6
Slaughter, R.S.7
Goetz, M.A.8
-
10
-
-
76949088921
-
-
50 value of 3.9 μM (ref. 4).
-
50 value of 3.9 μM (ref. 4).
-
-
-
-
11
-
-
34447625549
-
-
For recent excellent reviews on the voltage-gated potassium chanel Kv1.3 as a novel therapeutic target for autoimmune disorders, see
-
For recent excellent reviews on the voltage-gated potassium chanel Kv1.3 as a novel therapeutic target for autoimmune disorders, see. Wulff H., and Pennington M. Curr. Opin. Drug Discovery Dev. 10 (2007) 438
-
(2007)
Curr. Opin. Drug Discovery Dev.
, vol.10
, pp. 438
-
-
Wulff, H.1
Pennington, M.2
-
14
-
-
33645803847
-
-
Abe T., Iwasaki K., Inoue M., Suzuki T., Watanabe K., and Katoh T. Tetrahedron Lett. 47 (2006) 3251
-
(2006)
Tetrahedron Lett.
, vol.47
, pp. 3251
-
-
Abe, T.1
Iwasaki, K.2
Inoue, M.3
Suzuki, T.4
Watanabe, K.5
Katoh, T.6
-
15
-
-
24044505685
-
-
Watanabe K., Iwasaki K., Abe T., Inoue M., Ohkubo K., Suzuki T., and Katoh T. Org. Lett. 7 (2005) 3745
-
(2005)
Org. Lett.
, vol.7
, pp. 3745
-
-
Watanabe, K.1
Iwasaki, K.2
Abe, T.3
Inoue, M.4
Ohkubo, K.5
Suzuki, T.6
Katoh, T.7
-
16
-
-
76949088342
-
-
in press
-
T. Oguchi, K. Watanabe, K. Ohkubo, H. Abe, and T. Katoh, Chem. Eur. J., in press.
-
Chem. Eur. J
-
-
Oguchi, T.1
Watanabe, K.2
Ohkubo, K.3
Abe, H.4
Katoh, T.5
-
23
-
-
33645791244
-
-
For reviews on the [2,3]-Wittig rearrangement; see. Rappoport Z., and Marek I. (Eds), Wieley-VCH, Chichester
-
For reviews on the [2,3]-Wittig rearrangement; see. Tomooka K. In: Rappoport Z., and Marek I. (Eds). in the Chemistry of Functional Groups: the Patai Series Vol. 104 (2004), Wieley-VCH, Chichester 749-828
-
(2004)
in the Chemistry of Functional Groups: the Patai Series
, vol.104
, pp. 749-828
-
-
Tomooka, K.1
-
26
-
-
0000535071
-
-
Trost B.M., and Fleming I. (Eds), Pergamon, Oxford
-
Marshall J.A. In: Trost B.M., and Fleming I. (Eds). in Comprehensive Organic Synthesis Vol. 3 (1991), Pergamon, Oxford 975-1014
-
(1991)
in Comprehensive Organic Synthesis
, vol.3
, pp. 975-1014
-
-
Marshall, J.A.1
-
27
-
-
76949084722
-
-
A related Eschenmoser-Claisen rearrangement has been reported for the total synthesis of (±)-sesquicillin (see ref. 8), while, to the best of our knowledge, this type of [2,3]-Wittig rearrangement (cf. 9→8, Table 1) is unprecedented.
-
A related Eschenmoser-Claisen rearrangement has been reported for the total synthesis of (±)-sesquicillin (see ref. 8), while, to the best of our knowledge, this type of [2,3]-Wittig rearrangement (cf. 9→8, Table 1) is unprecedented.
-
-
-
-
29
-
-
30844472661
-
-
Katoh, Izuhara T., Yokota W., Inoue M., Watanabe K., Nobeyama A., and Suzuki T. Tetrahedron 62 (2006) 1590
-
(2006)
Tetrahedron
, vol.62
, pp. 1590
-
-
Katoh1
Izuhara, T.2
Yokota, W.3
Inoue, M.4
Watanabe, K.5
Nobeyama, A.6
Suzuki, T.7
-
30
-
-
4544239384
-
-
Inoue, Yokota W., Murugesh M.G., Izuhara T., and Katoh T. Angew. Chem. Int. Ed. 43 (2004) 4207
-
(2004)
Angew. Chem. Int. Ed.
, vol.43
, pp. 4207
-
-
Inoue1
Yokota, W.2
Murugesh, M.G.3
Izuhara, T.4
Katoh, T.5
-
32
-
-
76949085528
-
-
Although the absolute value of the synthetic material is somewhat smaller than that of natural product for some reason, we believe that the synthetic material is enantiomerically pure
-
Although the absolute value of the synthetic material is somewhat smaller than that of natural product for some reason, we believe that the synthetic material is enantiomerically pure.
-
-
-
|